Insulin detemir
地特胰岛素
Report date: 2026/01/23 09:55:49
Base Information
Drug NameInsulin detemir
Drug Alias Name +[12]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2004/06/01
Country/Territory +[32]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesNovo Nordisk Pharma LtdNovo Nordisk IncNovo Nordisk A/S +[4]
Inactive CompaniesWake Forest University Health SciencesMedical University Of GrazNational Heart, Lung, And Blood Institute (Nhlbi) +[4]
Active Indications +[4]
Inactive Indications +[7]